MARK SANDERS: Open Payments
NPI 1619018918 · ROCK SPRINGS, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,139 in 60 payments from 15 companies in 2025. Trend: 2023 $918 · 2024 $927 · 2025 $1,139
Food & beverage: $1,123Education: $16
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $225 |
| Lilly USA, LLC | 15 | $162 |
| Otsuka America Pharmaceutical, Inc. | 8 | $136 |
| Amgen Inc. | 6 | $99 |
| GlaxoSmithKline, LLC. | 4 | $95 |
| PFIZER INC. | 4 | $76 |
| Merck Sharp & Dohme LLC | 4 | $75 |
| ABBVIE INC. | 2 | $53 |
| Lundbeck LLC | 2 | $48 |
| Novo Nordisk Inc | 2 | $39 |
Products named: REXULTI, AIRSUPRA, MOUNJARO, TRELEGY ELLIPTA, NURTEC ODT, BREZTRI, VERQUVO, UBRELVY.
Industry payments across WY — which companies pay providers there.
